Position in GLUE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,106,986
+$7,854,153 QoQ
Shares Held
789,545
+15.4% QoQ
Ownership
0.925%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 193 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. GLUE ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in GLUE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,106,986 | 789,545 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $11,252,833 | 684,063 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,630,707 | 805,530 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,780,898 | 645,196 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,572,727 | 570,450 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,958,494 | 422,090 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,652,147 | 2,255,353 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $664,256 | 125,332 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $255,596 | 68,342 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $392,893 | 55,730 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $460,337 | 81,476 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $172,752 | 36,066 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $349,893 | 51,080 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $297,808 | 38,230 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $819,571 | 107,697 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $997,739 | 122,123 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,350,403 | 139,649 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,888,198 | 134,679 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,775,871 | 135,939 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,092,113 | 93,901 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||